Emil Walsted Nielsen1, James H Hull, Vibeke Backer. 1. 1Respiratory Research Unit, Department of Respiratory Medicine, Copenhagen University Hospital Bispebjerg, Copenhagen, DENMARK; and 2Department of Respiratory Medicine, Royal Brompton Hospital, London, England, UNITED KINGDOM.
Abstract
INTRODUCTION: Unexplained respiratory symptoms reported by athletes are often incorrectly considered secondary to exercise-induced asthma. We hypothesized that this may be related to exercise-induced laryngeal obstruction (EILO). This study evaluates the prevalence of EILO in an unselected cohort of athletes. METHODS: We retrospectively reviewed the prevalence of EILO in a cohort of athletes (n = 91) referred consecutively during a 2-yr period for asthma workup including continuous laryngoscopy during exercise (CLE) testing. We compared clinical characteristics and bronchial hyperreactivity between athletes with and without EILO. RESULTS: Of 88 athletes who completed a full workup, 31 (35.2%) had EILO and 38 (43.2%) had a positive bronchoprovocation or bronchodilator reversibility test. The presence of inspiratory symptoms did not differentiate athletes with and without EILO. Sixty-one percent of athletes with EILO and negative bronchoprovocation and bronchodilator reversibility tests used regular asthma medication at referral. CONCLUSIONS: In athletes with unexplained respiratory symptoms, EILO is an important differential diagnosis not discerned from other etiologies by clinical features. These findings have important implications for the assessment and management of athletes presenting with persistent respiratory symptoms despite asthma therapy.
INTRODUCTION: Unexplained respiratory symptoms reported by athletes are often incorrectly considered secondary to exercise-induced asthma. We hypothesized that this may be related to exercise-induced laryngeal obstruction (EILO). This study evaluates the prevalence of EILO in an unselected cohort of athletes. METHODS: We retrospectively reviewed the prevalence of EILO in a cohort of athletes (n = 91) referred consecutively during a 2-yr period for asthma workup including continuous laryngoscopy during exercise (CLE) testing. We compared clinical characteristics and bronchial hyperreactivity between athletes with and without EILO. RESULTS: Of 88 athletes who completed a full workup, 31 (35.2%) had EILO and 38 (43.2%) had a positive bronchoprovocation or bronchodilator reversibility test. The presence of inspiratory symptoms did not differentiate athletes with and without EILO. Sixty-one percent of athletes with EILO and negative bronchoprovocation and bronchodilator reversibility tests used regular asthma medication at referral. CONCLUSIONS: In athletes with unexplained respiratory symptoms, EILO is an important differential diagnosis not discerned from other etiologies by clinical features. These findings have important implications for the assessment and management of athletes presenting with persistent respiratory symptoms despite asthma therapy.
Authors: Emil S Walsted; Azmy Faisal; Caroline J Jolley; Laura L Swanton; Matthew J Pavitt; Yuan-Ming Luo; Vibeke Backer; Michael I Polkey; James H Hull Journal: J Appl Physiol (1985) Date: 2017-11-02
Authors: Emil S Walsted; Bamidele Famokunwa; Louise Andersen; Sune L Rubak; Frederik Buchvald; Lars Pedersen; James Dodd; Vibeke Backer; Kim G Nielsen; Andrew Getzin; James H Hull Journal: ERJ Open Res Date: 2021-06-28